Flu Vaccines
IDRI Makes Its Adjuvant Available to Increase Global Supply of Pandemic Vaccines
Published in Vaccine Weekly, June 24th, 2009
Following the World Health Organization (WHO) declaration of swine flu pandemic, the Infectious Disease Research Institute (IDRI) announced it has successfully developed an adjuvant that could significantly enhance both the effectiveness and supplies of pandemic flu vaccines. The Seattle-based not-for-profit organization will make its adjuvant technology available to flu vaccine manufacturers for the production of A (H1N1) or future pandemic flu vaccines.
"As stressed by Dr. Chan at today's press conference, there is a real urgency to address the needs of developing countries for adequate supplies of swine flu pandemic vaccines. She rightly urged for global solidarity...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2009-06-24)
More Articles from Vaccine Weekly
- Arthritis
One-year Phase III study shows Ilaris® offers rapid and sustained remission in patients with CAPS, a lifelong severe auto-inflammatory disease - Encephalitis
Reports summarize encephalitis study results from V.D. Krishna and co-researchers - Flu Vaccines
Scientists at University of Michigan target flu vaccines - Immunization
Research in the area of immunization reported from Novartis - Immunization
Research results from C. Cordonnier and co-authors update knowledge of immunization - Immunization
Scientists at Sanofi Pasteur report research in immunization - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
